Roche

Roche operates across two primary business divisions: pharmaceuticals and in-vitro diagnostics. The company combines these disciplines to develop therapies and diagnostic solutions aimed at preventing, stopping, or curing diseases with high societal burden. With over 125 years of continuous operation, Roche has established itself as a major presence in the biotech, healthcare, and pharmaceutical industries.

The company's approach centres on integrating drug development with diagnostic capabilities, enabling more precise healthcare outcomes. Roche maintains an extensive network of external collaborations, numbering over 250, to advance its research and development efforts. This collaborative model supports sustained investment in R&D and a long-term strategic vision.

Roche describes its culture as one driven by scientific excellence and a commitment to patient outcomes. The company emphasises integrity, courage, and calculated risk-taking, and states that it fosters an environment where diverse perspectives contribute to innovation. Success is measured against meaningful health improvements for patients.